Abstract：Objective To investigate the association of childhood hemophagocytic syndrome (HPS) with human parvovirus B19 (HPVB19) infection, and to analyze the clinical features of this disease. Methods ELISA and quantitative real-time PCR were used to detect HPVB19-IgM, HPVB19-IgG and HPVB19-DNA in 65 children with HPS (HPS group) and 65 healthy children (control group). The HPS group was divided into HPVB19-infected (n=14) and non-infected (n=51) groups according to the detection results of HPVB19-DNA. The clinical data of two groups were compared. Results The positive rate of HPVB19-IgM in the HPS group (26%, 17/65) was significantly higher than that in the control group (9%, 6/65) (P=0.011), and there was no significant difference in the positive rate of HPVB19-IgG between the HPS (38%, 25/65) and control groups (29%, 19/65) (P=0.266). The infection rate of HPVB19 in the HPS group (22%, 14/65) was significantly higher than that in the control group (3%, 2/65) (P=0.001). Compared with the noninfected group, the HPVB19-infected group had significantly lower platelet count and hemoglobin level on admission, significantly more severe liver function damage, a significantly earlier onset time, and a significantly longer course of disease (P<0.05). Conclusions The pathogenesis of HPS may be associated with HPVBl9 infection. HPVBl9-infected children with HPS have more acute onset, more severe clinical manifestations, and a longer disease duration.
WANG Ying-Chao,LIU Dong-Jie,MA Li-Na et al. Clinical features of childhood hemophagocytic syndrome and its association with human parvovirus B19 infection[J]. CJCP, 2015, 17(1): 26-30.
Tavera M, Petroni J, León L, et al. Reactive haemophagocytic syndrome associated with parvovirus B19 in a kidney-pancreas transplant patient[J]. Nefrologia, 2012, 32(1): 125-126.
[2]
Sood N, Yadav P. Hemophagocytic syndrome associated with concomitant Klebsiella and Parvovirus B-19 infection[J]. Indian J Pathol Microbiol, 2012, 55(1): 124-125.
[3]
Henter J, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[ J]. Pediatr Blood Cancer, 2007, 48(2): 124-131.
[4]
Filipovich AH. Hemophagocytic lymphohistiocytosis(HLH) and related disorders[J]. Hematology Am Soc Hematol Educ Program, 2009: 127-131.
[5]
Gupta V, Saini I, Nath G, et al. Prevalence of parvovirus B 19 infection in children with aplastic anemia[J]. Indian Pediatr, 2013, 50(5): 489-491.
Carreño MÁ, Wainstein E, Abumohor P. Parvovirus B19 arthritis: Report of three cases[J]. Rev Med Chil, 2012, 140(11): 1453-1456.
[8]
Alonso-Ojembarrena A, Alvarez-Coca J, Pérez-García MJ, et al. Henoch-Schönlein purpura due to parvovirus B19[J]. An Pediatr(Barc), 2006, 65(6): 641-642.
[9]
Molina KM, Garcia X, Denfield SW, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children[J]. Pediatr Cardiol, 2013, 34(2): 390-397.
[10]
Mihály I, Trethon A, Arányi Z, et al. Observations on human parvovirus B19 infection diagnosed in 2011[J]. Orv Hetil, 2012 Dec, 153(49): 1948-1957.
[11]
Abiodun I, Opaleye OO, Ojurongbe O, et al. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria[J]. J Infect Dev Ctries, 2013, 7(12): 946-950.
De Maria A, Zolezzi A, Passalacqua G, et al. Melkersson-Rosenthal syndrome associated with parvovirus B19 viraemia and haemophagocytic lymphohistiocytosis[J]. Clin Exp Dermatol, 2009, 34(8): e623-e625.
